<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04231825</url>
  </required_header>
  <id_info>
    <org_study_id>18-26268-1</org_study_id>
    <nct_id>NCT04231825</nct_id>
  </id_info>
  <brief_title>At-home Transcranial Alternating Current Stimulation During Multitasking</brief_title>
  <official_title>At-home Transcranial Alternating Current Stimulation During Multitasking</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal is to replicate in-lab results from transcranial alternating current stimulation&#xD;
      (tACS) with at-home tACS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be assessed in-lab on multitasking and sustained attention abilities.&#xD;
      Participants will be sent home with a tACS device to be used at-home for five days while&#xD;
      engaged in a multitasking paradigm that is different from the multitasking outcome measure&#xD;
      used pre/post tACS. After the at-home stimulation is complete, participants return to UCSF&#xD;
      for a final in-lab assessment of multitasking and sustained attention ability.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 15, 2019</start_date>
  <completion_date type="Actual">September 15, 2020</completion_date>
  <primary_completion_date type="Actual">August 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Multitasking Performance Cost (Neuroracer Performance Change From Baseline)</measure>
    <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
    <description>Assessment of multitasking ability using change from baseline scores in d' cost (metric of discriminability). Discrimination performance (d') was measured for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). d' cost was then calculated as the ratio of d' during single task target discrimination task to multitask target discrimination, expressed as percentage cost.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Single Task Performance Change</measure>
    <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
    <description>Discrimination performance (d') was measured during single task performance for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). Performance data was collected during the single task condition.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Multitask Performance Change</measure>
    <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
    <description>Discrimination performance (d') was measured while multitasking for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). Performance data was collected during the multitask condition.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Continuous Performance Test RT Change (Test of Visual Attention / Sustained Attention)</measure>
    <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
    <description>Assessment of sustained attention ability using response time (in ms) during the continuous performance test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continuous Performance Test RTV Change (Test of Visual Attention / Sustained Attention)</measure>
    <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
    <description>Assessment of sustained attention ability using response time variability (standard deviation of response times in ms) during the continuous performance test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Multitasking Behavior</condition>
  <arm_group>
    <arm_group_label>Verum Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive 6-Hz tACS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Frequency Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive 1-Hz tACS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial alternating current stimulation</intervention_name>
    <description>Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
    <arm_group_label>Frequency Control</arm_group_label>
    <arm_group_label>Verum Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
          -  Grade 12 or more education&#xD;
&#xD;
          -  Normal or corrected to normal vision and hearing&#xD;
&#xD;
          -  Ability to complete cognitive tasks&#xD;
&#xD;
          -  Ability to cooperate and comply with all study procedures&#xD;
&#xD;
          -  Ability to tolerate tACS&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neurological or psychiatric disorders&#xD;
&#xD;
          -  Family history of epilepsy&#xD;
&#xD;
          -  History of seizures&#xD;
&#xD;
          -  Prior head trauma&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Implanted electronic devices (e.g., pacemaker)&#xD;
&#xD;
          -  IQ &lt; 80&#xD;
&#xD;
          -  Taking psychotropic medication&#xD;
&#xD;
          -  Taking anti-depressants or anti-anxiety medication&#xD;
&#xD;
          -  Substance abuse&#xD;
&#xD;
          -  Color blind&#xD;
&#xD;
          -  Glaucoma&#xD;
&#xD;
          -  Macular degeneration&#xD;
&#xD;
          -  Amblyopia&#xD;
&#xD;
          -  Strabismus&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theodore Zanto, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sandler Neurosciences Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 8, 2019</study_first_submitted>
  <study_first_submitted_qc>January 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <results_first_submitted>August 11, 2021</results_first_submitted>
  <results_first_submitted_qc>September 29, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 28, 2021</results_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The dataset includes self-reported information, behavioral and electrophysiological data. The final dataset will be stripped of identifiers prior to release for sharing, thereby anonymizing the data. We will make the anonymized data available to users only under a data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and not to attempt to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed. This will be in accordance with human subject regulations.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>The data will be available after the results have been determined and the study researchers are unblinded. The data will be available indefinitely upon request.</ipd_time_frame>
    <ipd_access_criteria>Contact PI.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 11, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT04231825/Prot_SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 3, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT04231825/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Verum Stimulation</title>
          <description>This group will receive 6-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
        </group>
        <group group_id="P2">
          <title>Frequency Control</title>
          <description>This group will receive 1-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Only data from participants who completed the full protocol were analyzed</population>
      <group_list>
        <group group_id="B1">
          <title>Verum Stimulation</title>
          <description>This group will receive 6-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
        </group>
        <group group_id="B2">
          <title>Frequency Control</title>
          <description>This group will receive 1-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="47"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.8" spread="4.6"/>
                    <measurement group_id="B2" value="24.6" spread="4.2"/>
                    <measurement group_id="B3" value="25.2" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Single Task Performance</title>
          <description>Discrimination performance (d') was measured for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). Performance was collected during the single task condition.</description>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>d'</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.73" spread="0.63"/>
                    <measurement group_id="B2" value="2.01" spread="0.63"/>
                    <measurement group_id="B3" value="1.87" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Multitask performance</title>
          <description>Discrimination performance (d') was measured for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). Performance was collected during the multitasking condition.</description>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>d'</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.03" spread="0.63"/>
                    <measurement group_id="B2" value="1.20" spread="0.58"/>
                    <measurement group_id="B3" value="1.12" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Multitasking Cost Performance</title>
          <description>Discrimination performance (d') was measured for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). Ratio of d' during single task target discrimination task to multitask target discrimination, expressed as percentage.</description>
          <population>Only data from participants who completed the full protocol were analyzed.</population>
          <units>Percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.8" spread="0.40"/>
                    <measurement group_id="B2" value="40.5" spread="0.22"/>
                    <measurement group_id="B3" value="43.2" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Continuous Performance Task RT</title>
          <description>Response times (in ms) during the continuous performance (sustained attention) task.</description>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="322" spread="43"/>
                    <measurement group_id="B2" value="322" spread="34"/>
                    <measurement group_id="B3" value="322" spread="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Continuous Performance Task RTV</title>
          <description>Response time variability (standard deviation of response times in ms) during the continuous performance (sustained attention) task</description>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76" spread="7"/>
                    <measurement group_id="B2" value="65" spread="5"/>
                    <measurement group_id="B3" value="71" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Multitasking Performance Cost (Neuroracer Performance Change From Baseline)</title>
        <description>Assessment of multitasking ability using change from baseline scores in d' cost (metric of discriminability). Discrimination performance (d') was measured for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). d' cost was then calculated as the ratio of d' during single task target discrimination task to multitask target discrimination, expressed as percentage cost.</description>
        <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
        <population>Only data from participants who completed the full protocol were analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Verum Stimulation</title>
            <description>This group will receive 6-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
          </group>
          <group group_id="O2">
            <title>Frequency Control</title>
            <description>This group will receive 1-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
          </group>
        </group_list>
        <measure>
          <title>Multitasking Performance Cost (Neuroracer Performance Change From Baseline)</title>
          <description>Assessment of multitasking ability using change from baseline scores in d' cost (metric of discriminability). Discrimination performance (d') was measured for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). d' cost was then calculated as the ratio of d' during single task target discrimination task to multitask target discrimination, expressed as percentage cost.</description>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>d' % change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.3" spread="0.31"/>
                    <measurement group_id="O2" value="37.9" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.55</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Continuous Performance Test RT Change (Test of Visual Attention / Sustained Attention)</title>
        <description>Assessment of sustained attention ability using response time (in ms) during the continuous performance test</description>
        <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
        <population>Only data from participants who completed the full protocol were analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Verum Stimulation</title>
            <description>This group will receive 6-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
          </group>
          <group group_id="O2">
            <title>Frequency Control</title>
            <description>This group will receive 1-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
          </group>
        </group_list>
        <measure>
          <title>Continuous Performance Test RT Change (Test of Visual Attention / Sustained Attention)</title>
          <description>Assessment of sustained attention ability using response time (in ms) during the continuous performance test</description>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="300" spread="42"/>
                    <measurement group_id="O2" value="303" spread="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.51</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Continuous Performance Test RTV Change (Test of Visual Attention / Sustained Attention)</title>
        <description>Assessment of sustained attention ability using response time variability (standard deviation of response times in ms) during the continuous performance test</description>
        <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
        <population>Only data from participants who completed the full protocol were analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Verum Stimulation</title>
            <description>This group will receive 6-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
          </group>
          <group group_id="O2">
            <title>Frequency Control</title>
            <description>This group will receive 1-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
          </group>
        </group_list>
        <measure>
          <title>Continuous Performance Test RTV Change (Test of Visual Attention / Sustained Attention)</title>
          <description>Assessment of sustained attention ability using response time variability (standard deviation of response times in ms) during the continuous performance test</description>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58" spread="26"/>
                    <measurement group_id="O2" value="56" spread="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.80</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Single Task Performance Change</title>
        <description>Discrimination performance (d') was measured during single task performance for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). Performance data was collected during the single task condition.</description>
        <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
        <population>Only data from participants who completed the full protocol were analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Verum Stimulation</title>
            <description>This group will receive 6-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
          </group>
          <group group_id="O2">
            <title>Frequency Control</title>
            <description>This group will receive 1-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
          </group>
        </group_list>
        <measure>
          <title>Single Task Performance Change</title>
          <description>Discrimination performance (d') was measured during single task performance for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). Performance data was collected during the single task condition.</description>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>d'</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.99" spread="0.94"/>
                    <measurement group_id="O2" value="2.70" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Multitask Performance Change</title>
        <description>Discrimination performance (d') was measured while multitasking for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). Performance data was collected during the multitask condition.</description>
        <time_frame>Pre-tACS and post-tACS (1 week later)</time_frame>
        <population>Only data from participants who completed the full protocol were analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Verum Stimulation</title>
            <description>This group will receive 6-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
          </group>
          <group group_id="O2">
            <title>Frequency Control</title>
            <description>This group will receive 1-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
          </group>
        </group_list>
        <measure>
          <title>Multitask Performance Change</title>
          <description>Discrimination performance (d') was measured while multitasking for each participant by comparing hit (correct responses to target signs) rates and false alarm (responses to non-targets) rates and calculated as d' = Z (hits) - Z (false alarms). Performance data was collected during the multitask condition.</description>
          <population>Only data from participants who completed the full protocol were analyzed</population>
          <units>d'</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.17" spread="0.76"/>
                    <measurement group_id="O2" value="1.79" spread="0.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>10 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Verum Stimulation</title>
          <description>This group will receive 6-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
        </group>
        <group group_id="E2">
          <title>Frequency Control</title>
          <description>This group will receive 1-Hz tACS&#xD;
Transcranial alternating current stimulation: Transcranial alternating current stimulation across the prefrontal cortex using electrodes F3 and F4.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Other (Not Including Serious) Adverse Event</sub_title>
                <description>Device malfunction.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Theodore Zanto</name_or_title>
      <organization>University of California San Francisco</organization>
      <phone>415-502-7322</phone>
      <email>theodore.zanto@ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

